Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

763 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk factors for nephrotoxicity in patients treated with aminoglycosides.
Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Moore RD, et al. Ann Intern Med. 1984 Mar;100(3):352-7. doi: 10.7326/0003-4819-100-3-352. Ann Intern Med. 1984. PMID: 6364908 Clinical Trial.
A model for predicting nephrotoxicity in patients treated with aminoglycosides.
Sawyers CL, Moore RD, Lerner SA, Smith CR. Sawyers CL, et al. J Infect Dis. 1986 Jun;153(6):1062-8. doi: 10.1093/infdis/153.6.1062. J Infect Dis. 1986. PMID: 3701117
Studies of risk factors for aminoglycoside nephrotoxicity.
Smith CR, Moore RD, Lietman PS. Smith CR, et al. Am J Kidney Dis. 1986 Nov;8(5):308-13. doi: 10.1016/s0272-6386(86)80103-2. Am J Kidney Dis. 1986. PMID: 3538855 Clinical Trial.
Comparative cost effectiveness of gentamicin and tobramycin.
Holloway JJ, Smith CR, Moore RD, Feroli ER Jr, Lietman PS. Holloway JJ, et al. Ann Intern Med. 1984 Dec;101(6):764-9. doi: 10.7326/0003-4819-101-6-764. Ann Intern Med. 1984. PMID: 6437310 Clinical Trial.
Lack of evidence for interaction between tobramycin and shock in their effect on renal function.
Ambinder RF, Moore RD, Smith CR, Mellits ED, Lietman PS. Ambinder RF, et al. Antimicrob Agents Chemother. 1985 Feb;27(2):217-9. doi: 10.1128/aac.27.2.217. Antimicrob Agents Chemother. 1985. PMID: 3885850 Free PMC article. Clinical Trial.
763 results
Jump to page
Feedback